Abstract
Publication details
- DOI
- 10.18295/squmj.2021.21.02.027
- Journal
- Sultan Qaboos University Medical Journal, 21(2), e327-328
- Publisher
- Sultan Qaboos University
- Open access
- Gold open access
- License
- CC BY-ND 4.0
Cite this article
APA 7
Burney, I. A., Kakaria, A. K., & Al Jahdhami, S. (2025). Complete Response to Sorafenib in Locally Recurrent Unresectable Aggressive Fibromatosis. Sultan Qaboos University Medical Journal, 21(2), e327-328. https://doi.org/10.18295/squmj.2021.21.02.027
MLA 9
Burney, Ikram A., et al. "Complete Response to Sorafenib in Locally Recurrent Unresectable Aggressive Fibromatosis." Sultan Qaboos University Medical Journal, vol. 21, no. 2, 2025, pp. e327-328. https://doi.org/10.18295/squmj.2021.21.02.027.
Chicago (author–date)
Burney, Ikram A., Anupam K. Kakaria, and Suad Al Jahdhami. 2025. "Complete Response to Sorafenib in Locally Recurrent Unresectable Aggressive Fibromatosis." Sultan Qaboos University Medical Journal 21 (2): e327-328. https://doi.org/10.18295/squmj.2021.21.02.027.
Harvard
Burney, I. A., Kakaria, A. K. and Al Jahdhami, S. (2025) 'Complete Response to Sorafenib in Locally Recurrent Unresectable Aggressive Fibromatosis', Sultan Qaboos University Medical Journal, 21(2), pp. e327-328. doi:10.18295/squmj.2021.21.02.027.
Vancouver
Burney IA, Kakaria AK, Al Jahdhami S. Complete Response to Sorafenib in Locally Recurrent Unresectable Aggressive Fibromatosis. Sultan Qaboos University Medical Journal. 2025;21(2):e327-328. doi:10.18295/squmj.2021.21.02.027
IEEE
I. A. Burney, A. K. Kakaria, and S. Al Jahdhami, "Complete Response to Sorafenib in Locally Recurrent Unresectable Aggressive Fibromatosis," Sultan Qaboos University Medical Journal, vol. 21, no. 2, pp. e327-328, 2025, doi: 10.18295/squmj.2021.21.02.027.